BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3300292)

  • 1. A comparison of betaxolol and nadolol on renal function in essential hypertension.
    Bauer JH; Reams GP; Lau A
    Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
    Reams GP; Bauer JH; Lau A
    J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertension.
    Madonna O; Labeeuw M; Pozet N; Aissa AH; Zech P
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):133-7. PubMed ID: 3410595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
    Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two doses of betaxolol and placebo in hypertension: a randomized, double-blind cross-over trial.
    Salonen JT; Palminteri R
    Eur J Clin Pharmacol; 1982; 23(6):491-4. PubMed ID: 6761136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
    Pun KK; Yeung CK; Chan MK
    Br J Clin Pharmacol; 1985 Oct; 20(4):401-4. PubMed ID: 3907676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
    O'Connor DT; Barg AP; Duchin KL
    J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion.
    Waller DG; Mihindukulasuriya J; Warren DJ
    Br J Clin Pharmacol; 1985 Jan; 19(1):37-43. PubMed ID: 2858216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaxolol and timolol. A comparison of efficacy and side effects.
    Berry DP; Van Buskirk EM; Shields MB
    Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.